CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-23 | HESTERBERG LYNDAL K. Sr VP, Research & Development | Grant or award · Option to Purchase Common Stock | +150,000 | 150,000 | ||
| 2018-05-23 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2018-05-23 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +125,000 | 125,000 |
Page 20 of 20 · 383 trades